Recro Pharma Inc (REPH)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1 E. UWCHLAN AVE, SUITE 112 EXTON, PA 19341

Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market.

Data as of 2021-10-09 10:07:09 -0400
Market Cap88.568 Million Shares Outstanding46.615 Million Avg 30-day Volume295.626 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-7.81 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.75533 52-week High/Low5.29 / 1.49 Next Earnings Date2021-11-09 Price to Cash FLow (P/CF) 51.8783
Data provided by IEX Cloud
View SEC Filings from REPH instead.

View recent insider trading info

Funds Holding REPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding REPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LAKE RYAN DAVID CHIEF FINANCIAL OFFICER

  • Officer
373,173 2021-07-08 9

PARKS LAURA L.

  • Director
20,000 2021-06-14 2

AWM INVESTMENT COMPANY, INC.

  • 10% Owner
No longer subject to file 2021-06-10 2

CHURCHILL WINSTON J

  • Director
38,012 2021-04-20 2

HENWOOD GERALDINE

  • Director
38,012 2021-04-20 6

ASHTON WILLIAM

  • Director
38,012 2021-04-20 2

BERELOWITZ MICHAEL

  • Director
38,012 2021-04-20 2

REASONS BRYAN M.

  • Director
38,012 2021-04-20 2

WEISMAN WAYNE

  • Director
38,012 2021-04-20 2

MILLER JAMES CHARLES

  • Director
38,012 2021-04-20 4

SCP VITALIFE PARTNERS II LP

  • 10% Owner
2,097,938 2020-12-22 2

SCP VITALIFE PARTNERS (ISRAEL) II, L.P.

  • 10% Owner
701,017 2020-12-22 2

ENLOE J DAVID JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-12-15 2

AJDLER ARNAUD

  • Director
1,128,303 2020-05-07 0

ALTOMARI ALFRED

  • Director
44,196 2019-12-05 0

FLYNN KAREN

  • Director
39,283 2019-12-05 0

CELANO MICHAEL CHIEF OPERATING OFFICER

  • Officer
44,063 2019-01-18 0

BROADFIN HEALTHCARE MASTER FUND LTD

BROADFIN CAPITAL, LLC

KOTLER KEVIN

  • 10% Owner
No longer subject to file 2018-05-24 0

MYERS DIANE SENIOR VP-REG/QUALITY

  • Officer
18,528 2018-01-18 0

MACK RANDALL SENIOR VP, DEVELOPMENT

  • Officer
33,752 2018-01-18 0

MCCALLUM STEWART CHIEF MEDICAL OFFICER

  • Officer
31,841 2018-01-18 0

GRAFF FRED CHIEF COMMERCIAL OFFICER

  • Officer
27,083 2018-01-18 0

MATTILA JYRKI EXECUTIVE VP, BUSINESS DEV.

  • Officer
11,500 2018-01-02 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2017-06-12 0

STONEPINE CAPITAL MANAGEMENT, LLC

  • 10% Owner
No longer subject to file 2017-05-12 0

NICHOLS DONNA CAO/CONTROLLER

  • Officer
0 2017-01-18 0

LUDOMIRSKI ABRAHAM

  • Director
0 2015-12-16 0

GARNER CHARLES CFO AND CHIEF BUSINESS OFFICER

  • Officer
5,000 2015-06-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
RECRO PHARMA INC REPH 2021-10-15 22:15:04 UTC -0.1933 0.2633 450000
RECRO PHARMA INC REPH 2021-10-15 21:45:03 UTC -0.1933 0.2633 450000
RECRO PHARMA INC REPH 2021-10-15 21:15:03 UTC -0.1933 0.2633 450000
RECRO PHARMA INC REPH 2021-10-15 20:45:03 UTC -0.1933 0.2633 450000
RECRO PHARMA INC REPH 2021-10-15 20:15:03 UTC -0.1933 0.2633 450000
RECRO PHARMA INC REPH 2021-10-15 19:45:03 UTC -0.1933 0.2633 450000
RECRO PHARMA INC REPH 2021-10-15 19:15:04 UTC -0.1933 0.2633 450000
RECRO PHARMA INC REPH 2021-10-15 18:45:03 UTC -0.2183 0.2883 450000
RECRO PHARMA INC REPH 2021-10-15 18:15:03 UTC -0.2183 0.2883 450000
RECRO PHARMA INC REPH 2021-10-15 17:45:03 UTC -0.2183 0.2883 450000
RECRO PHARMA INC REPH 2021-10-15 17:15:03 UTC -0.2183 0.2883 450000
RECRO PHARMA INC REPH 2021-10-15 16:45:03 UTC -0.2609 0.3309 450000
RECRO PHARMA INC REPH 2021-10-15 16:15:03 UTC -0.2609 0.3309 450000
RECRO PHARMA INC REPH 2021-10-15 15:45:03 UTC -0.2609 0.3309 450000
RECRO PHARMA INC REPH 2021-10-15 15:15:03 UTC -0.2609 0.3309 450000
RECRO PHARMA INC REPH 2021-10-15 14:45:02 UTC -0.1847 0.2547 500000
RECRO PHARMA INC REPH 2021-10-15 14:15:03 UTC -0.1847 0.2547 500000
RECRO PHARMA INC REPH 2021-10-15 13:45:03 UTC -0.1847 0.2547 500000
RECRO PHARMA INC REPH 2021-10-15 13:15:03 UTC -0.1847 0.2547 500000
RECRO PHARMA INC REPH 2021-10-15 12:45:03 UTC -0.1847 0.2547 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments